CUSIP: 501570105
Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,758,596
-
Share change
-
+128,848
-
Total reported value
-
$587,303,614
-
Price per share
-
$37.32
-
Number of holders
-
90
-
Value change
-
+$4,615,344
-
Number of buys
-
5
-
Number of sells
-
1
Quarterly Holders Quick Answers
What is CUSIP 501570105?
CUSIP 501570105 identifies KYTH - KYTHERA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2014
-
Previous quarter:
Q3 2013
Recent filing periods for CUSIP 501570105:
Institutional Holders of KYTHERA BIOPHARMACEUTICALS I - COM (KYTH) as of Q4 2013
As of 31 Dec 2013,
KYTHERA BIOPHARMACEUTICALS I - COM (KYTH) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,758,596 shares.
The largest 10 holders included
FMR LLC, JENNISON ASSOCIATES LLC, WADDELL & REED FINANCIAL INC, ADAGE CAPITAL PARTNERS GP LLC, Palo Alto Investors, LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Partner Fund Management, L.P., BlackRock Fund Advisors, Redmile Group, LLC, and State Street Corp.
This page lists
90
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.